Subscribe to RSS

Skin Patch approved by FDA for Migraines

Posted on 20. Jan, 2013 by in Health, Health Featured

The Zecuity skin patch has been approved by the U.S. Food and Health Administration for use by adults who suffer from migraines with an aura or without

The Zecuity skin patch has been approved by the U.S. Food and Health Administration for use by adults who suffer from migraines with an aura or without

January 20, 2013 - The Zecuity skin patch has been approved by the U.S. Food and Health Administration for use by adults who suffer from migraines with an aura or without. The single-use only battery powered skin patch offers relief of nausea caused by migraines, as well as the migraine headache itself.   Over 16 million adults in the U.S. suffer migraines.

Eight million of those also have nausea that is migraine related and usually avoid use of any oral medications. Along with the severe pain from the migraine, patients with have other significant symptoms, which can commonly include nausea said the patch’s manufacturer NuPathe Inc.

The patch can be applied to the area of the upper thigh or arm during the migraine and then activated by pushing a button Medicine is delivered via the patch through the wearer’s skin bypassing the patient’s stomach. Over a four-hour period, 6.5 milligrams of medication are delivered.

Studies of over 800 patients with migraines who used over 10,000 patches showed the patch effectively and safely relieved pain from migraines, nausea related to migraines and light and sound sensitivity within the first two hours of use.

The tests showed that after two hours of use 18% of the patients with the patch no longer had a headache, compared to just 9% of those who used a placebo. After two hours of use, 53% of those wearing patches, had some form of relief to their headache, compared to 29% who had just placebos. In addition, after just two hours, 84% using the patch did not have nausea, compared with 63% of those who received just a placebo.

Common side effects with the medication occurred in over 5% of the patients. The side effects included tingling at the patch site, warmth, itching and some discomfort. People with high blood pressure that is uncontrollable or with heart disease should not take the drug.

0 comments

Other articlesgo to homepage

AbbVie Beats Estimates during First Quarter

AbbVie Beats Estimates during First Quarter(0)

April 28, 2013 - AbbVie announced on Friday that it could earn up to $1.5 billion more in annual revenue from is rheumatoid arthritis medication Humira, which already makes up 50% of its overall revenue, as new uses are approved for the medication. Humira’s sales during the first quarter were up by 16% from the same

Vaccine Trial for HIV Shuttered

Vaccine Trial for HIV Shuttered(0)

April 26, 2013- Federal researchers have shuttered a clinical trial for a vaccine for HIV that involved more than 2,500 subjects. The trial was ended after researchers found that it was ineffective at preventing subjects who were healthy from contracting HIV. The major setback came about when safety experts from an independent panel determined that

Hundreds of Undocumented Immigrants Sent Home by Hospitals in U.S.

Hundreds of Undocumented Immigrants Sent Home by Hospitals in U.S.(0)

April 24, 2013 - Hundreds of immigrants that were in the U.S. illegally have been transported back to their home countries by hospitals in the U.S. This little known or heard off system of removal is not run by the government, but by individual hospitals who seek to lower their costs. A report recently published compiled

AIDS: 1.8 million children orphaned in Nigeria

AIDS: 1.8 million children orphaned in Nigeria(0)

April 21, 2013 - Medical experts estimate that over 1.8 million children in Nigeria have been orphaned because of AIDS since 1986 when the first case was identified of the pandemic in the country. The Ministry of Health in the country spoke of the problems the children are facing during a five-day workshop to help give

Authorities accuse Glaxo of Paying to delay Generic Medicines

Authorities accuse Glaxo of Paying to delay Generic Medicines(0)

April 19, 2013 - GlaxoSmithKline the UK pharmaceutical giant was accused of paying their rivals to slow production of generic versions of the company’s most profitable antidepressant medication. The Office of Fair Trading in Britain has launched the investigation into the alleged payoffs by GSK to keep the sales of its drug Seroxat high. The alleged

read more

Headlines

Genocide Trial in Guatemalan Suspended Genocide Trial in Guatemalan Suspended
One Suspect in Boston Killed, one on the run One Suspect in Boston Killed, one on the run
Musharraf Flees as Bail is Revoked Musharraf Flees as Bail is Revoked
Some Say New Immigration Bill too Stringent Some Say New Immigration Bill too Stringent
read more

Sponsors